雷洛昔芬(Evista)正品原研药最新价格表

Raloxifene (Evista), a classic drug for the treatment of postmenopausal osteoporosis, works by selectively regulating estrogen receptors and has the dual benefits of increasing bone density and reducing the risk of breast cancer.

The latest price list of the genuine original brand drug Raloxifene (Evista)

Raloxifene has been launched in mainland China and has been included in the national medical insurance reimbursement catalog. The genuine product currently circulating on the market is produced by Eli Lilly and Company of the United States. The specification is 60mg*100 tablets/box, and the price per box is about US$70.

In addition, there are genuine products produced by Japan's Nippon Medical Industry Co., Ltd., and the price of products with the same specifications is about US$42. After purchasing the medicine, please keep the prescription and invoice to facilitate subsequent medication consultation.

Special medication groups for raloxifene (Evista)

Raloxifene is not suitable for all people. The following patients must strictly follow the doctor's guidance.

Pregnant women and women of childbearing age

It is prohibited to be used by pregnant women. Animal experiments show that it may cause abnormal fetal development. Breastfeeding women should stop breastfeeding when taking the drug, as the drug ingredients may interfere with the growth and development of the baby. It is not recommended for women who are not yet menopausal (including perimenopausal women). This drug is only suitable for women who have experienced natural or surgical menopause for more than 1 year.

Patients at risk of thrombosis

It is contraindicated in patients with a history of deep vein thrombosis and pulmonary embolism. Patients who are bedridden for more than 72 hours, have recently undergone joint replacement surgery, or have malignant tumors need to suspend medication.

The 4 months before treatment is a period of high incidence of thrombosis. When taking a long-distance flight, you should move your lower limbs every hour and wear medical elastic stockings to prevent thrombosis.

Patients with chronic organ dysfunction

Patients with moderate or above renal insufficiency (eGFR <45mL/min) need to reduce the dosage to 1 tablet every other day and monitor creatinine clearance every quarter. Use with caution in patients with abnormal liver function. The drug should be discontinued when transaminase exceeds 3 times the normal value.

Patients with cardiovascular and cerebrovascular diseases need to control their blood pressure <140/90mmHg, and seek medical attention immediately if they experience sudden headaches or blurred vision.

Daily care for patients with osteoporosis

Coupled with drug treatment, scientific life management can significantly improve the efficacy.

Precision nutrition supplement plan

Supplement 1500mg of elemental calcium in divided doses daily, and avoid taking it with iron supplements. Daily intake of vitamin D is 800IU, and exposure to the sun for 15 minutes before 10 a.m. promotes synthesis. Increase your intake of magnesium-rich foods to relieve leg cramps caused by medication.

Fall prevention and environmental modification

Lay anti-slip mats in the bathroom, install L-shaped handrails, and keep night lights in the bedroom always on. Wear flat, non-slip shoes when going out, and use a walker in rainy or snowy weather. Have your eyesight checked every year and replace your glasses with appropriate power in a timely manner. Participate in Tai Chi or water sports 3 times a week to enhance your balance. Protective covers are installed on sharp corners of furniture, and wires on the ground are neatly stored.

During the medication, hot flashes, leg cramps, joint pain and other discomforts may occur. You should explain it to your doctor in time and follow the doctor's instructions for corresponding treatment.